Helen Cobb joined Vernalis in 2008 after several years working in DMPK at UCB. Helen has over 20 years industry experience and is adept at in vitro DMPK assays, bioanalysis and metabolite identification. Her career highlight was PK/PD bioanalysis for a FAAH inhibition project by monitoring multiple biomarkers in plasma and tissues, culminating in processing phase I clinical data. Helen enjoys applying her technical skills to different disciplines to advance project progression eg in vitro cellular penetration. A recent focus on bacterial uptake has started a new interest but DMPK remains her main focus.
